ALTAltimmune, Inc.

Nasdaq altimmune.com


$ 6.40 $ 0.47 (7.91 %)    

Friday, 21-Jun-2024 15:59:55 EDT
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 6.41
$ 6.10
$ 0.00 x 0
$ 0.00 x 0
$ 6.03 - $ 6.72
$ 2.09 - $ 14.84
10,896,012
na
453.84M
$ 0.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-13-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 03-14-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 03-11-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-11-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-altimmune-maintains-25-price-target

Piper Sandler analyst Yasmeen Rahimi maintains Altimmune (NASDAQ:ALT) with a Overweight and maintains $25 price target.

 altimmune-presents-new-data-on-pemvidutides-benefits-for-liver-disease-and-obesity-at-easl-congress

Altimmune, Inc. (NASDAQ:ALT), a clinical-stage biopharmaceutical company, today presented new data on the potential anti-inflam...

 hc-wainwright--co-reiterates-buy-on-altimmune-maintains-12-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Altimmune (NASDAQ:ALT) with a Buy and maintains $12 price target.

 jmp-securities-maintains-market-outperform-on-altimmune-lowers-price-target-to-24

JMP Securities analyst Jonathan Wolleben maintains Altimmune (NASDAQ:ALT) with a Market Outperform and lowers the price targ...

 jim-cramer-calls-nutanix-the-perfect-enterprise-software-company-for-the-moment

Cramer discusses Agnico Eagle Mines, Nutanix, Altimmune, CVR Energy and Quanta Services on CNBC's "Mad Money."

 guggenheim-downgrades-altimmune-to-neutral

Guggenheim analyst Seamus Fernandez downgrades Altimmune (NASDAQ:ALT) from Buy to Neutral.

 hc-wainwright--co-maintains-buy-on-altimmune-lowers-price-target-to-12

HC Wainwright & Co. analyst Patrick Trucchio maintains Altimmune (NASDAQ:ALT) with a Buy and lowers the price target fro...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

 b-riley-securities-reiterates-buy-on-altimmune-maintains-20-price-target

B. Riley Securities analyst Mayank Mamtani reiterates Altimmune (NASDAQ:ALT) with a Buy and maintains $20 price target.

 rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

 why-is-obesity-drug-developer-altimmune-stock-trading-lower-on-wednesday

Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipos...